RESUMO
OBJECTIVE: Improving shared decision-making (SDM) enables more tailored cancer treatment decisions. We evaluated a Time Out consultation (TOC) with the general practitioner (GP), between cancer diagnosis and treatment decision, which aims at supporting SDM and improving continuity of primary care. This study aims to evaluate the effects of a TOC on perceived SDM, information provision and self-efficacy. METHODS: This randomised controlled trial included newly diagnosed patients with curable cancer (breast, lung, colorectal, gynaecologic and melanoma) from four Dutch hospitals. Primary outcome is perceived SDM and secondary outcomes are information provision and self-efficacy. RESULTS: One hundred fifty-four patients (control n = 77, intervention n = 77) - female: 75%, mean age: 61 (SD ± 11.9). In the intervention group, 80.5% (n = 62) had a TOC, of which 82.3% (n = 51) took place after treatment decision. Perceived SDM was lower in the intervention group (-8.9 [95% CI: 0.6-17.1]). Among those with a TOC before treatment decision (n = 11), perceived SDM was comparable to the control group (66.5 ± 27.2 vs. 67.9 ± 26.1). CONCLUSION: Even though patients are motivated to have a TOC, implementing a TOC between diagnosis and treatment decision is challenging. Effects of a timely TOC could not be established. Non-timely TOC decreased perceived SDM. Planning of the TOC should be optimised, and future research should establish if adequately timed TOC results in improved SDM in cancer patients.
Assuntos
Clínicos Gerais , Neoplasias , Tomada de Decisões , Tomada de Decisão Compartilhada , Feminino , Humanos , Pessoa de Meia-Idade , Neoplasias/terapia , Participação do Paciente , Encaminhamento e ConsultaRESUMO
A 39-year-old woman was referred to the Dermatology outpatient clinic with a bleeding umbilical nodule. A Sister Mary Joseph's nodule - an ominous sign of periumbilical cutaneous metasasis - was in the differential diagnosis. However, punch biopsy of the nodule revealed cutaneous endometriosis.
Assuntos
Endometriose/diagnóstico , Hemorragia/diagnóstico , Adulto , Biópsia , Diagnóstico Diferencial , Feminino , Humanos , Nódulo da Irmã Maria José/diagnóstico , Umbigo/patologiaAssuntos
Anticorpos Monoclonais Humanizados/uso terapêutico , Inativadores do Complemento/uso terapêutico , Hemoglobinúria Paroxística/complicações , Hemoglobinúria Paroxística/terapia , Tromboembolia/radioterapia , Tromboembolia/terapia , Feminino , Humanos , Pessoa de Meia-Idade , Infecções por Parvoviridae/complicações , Parvovirus B19 Humano , RecidivaAssuntos
Dessensibilização Imunológica/métodos , Hipersensibilidade a Noz/prevenção & controle , Rinite Alérgica Sazonal/prevenção & controle , Adulto , Betula/imunologia , Separação Celular , Corylus/imunologia , Reações Cruzadas , Método Duplo-Cego , Feminino , Citometria de Fluxo , Humanos , Imunoglobulina E/sangue , Imunoglobulina G/sangue , Masculino , Hipersensibilidade a Noz/imunologia , Pólen/imunologia , Teste de Radioalergoadsorção , Rinite Alérgica Sazonal/imunologia , Testes CutâneosRESUMO
BACKGROUND: The impact of peanut allergy is large and accidental ingestion of peanut can lead to severe reactions. Currently used diagnostic tests, such as skin prick tests (SPT) and determination of specific immunoglobulins (IgE) have, however, limited sensitivity and specificity. Therefore, new tools have to be developed to improve the accuracy of the diagnostic work-up of food-allergic patients. Comprehensive metabolite analysis may provide biomarkers for diagnosing food allergy as metabolite levels reflect actual physiological conditions. We investigated whether metabolites can be found that discriminate between peanut-allergic patients and non-peanut-allergic subjects. Such metabolites may be used for future diagnostic purposes. METHODS: Plasma and saliva samples were obtained from 23 participants (12 peanut allergic and 11 peanut tolerant) prior to and after a peanut challenge and measured with (1)H nuclear magnetic resonance (NMR) spectroscopy with subsequent multivariate data analysis. RESULTS: Clear differences were observed between NMR spectra of peanut-allergic and peanut-tolerant subjects in plasma as well as saliva. Allergic patients already showed aberrant metabolite levels prior to peanut ingestion, thus before the onset of allergic reactions. CONCLUSION: This pilot study shows that aberrant metabolite levels as determined by NMR in combination with multivariate statistics may serve as novel biomarkers for food allergy.
Assuntos
Biomarcadores/metabolismo , Hipersensibilidade a Amendoim/diagnóstico , Hipersensibilidade a Amendoim/metabolismo , Adolescente , Adulto , Alérgenos/imunologia , Arachis/imunologia , Biomarcadores/análise , Biomarcadores/sangue , Creatinina/sangue , Análise Discriminante , Feminino , Glutamina/sangue , Humanos , Imunoglobulina E/sangue , Imunoglobulina E/imunologia , Ácido Láctico/sangue , Lipídeos/sangue , Espectroscopia de Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Niacina/sangue , Hipersensibilidade a Amendoim/imunologia , Projetos Piloto , Análise de Componente Principal , Saliva/metabolismo , Processamento de Sinais Assistido por Computador , Triptofano/sangue , Tirosina/sangue , Adulto JovemRESUMO
BACKGROUND: Reports of lupine allergy are increasing as its use in food products increases. Lupine allergy might be the consequence of cross-reactivity after sensitization to peanut or other legumes or de novo sensitization. Lupine allergens have not been completely characterized. OBJECTIVES: We sought to identify allergens associated with lupine allergy, evaluate potential cross-reactivity with peanut, and determine eliciting doses (EDs) for lupine allergy by using double-blind, placebo-controlled food challenges. METHODS: Six patients with a history of allergic reactions to lupine flour were evaluated by using skin prick tests, CAP tests, and double-blind, placebo-controlled food challenges. Three of these patients were also allergic to peanut. Lupine allergens were characterized by means of IgE immunoblotting and peptide sequencing. RESULTS: In all 6 patients the ED for lupine flour was 3 mg or less for subjective symptoms and 300 mg or more for objective symptoms. The low ED and moderate-to-severe historical symptoms indicate significant allergenicity of lupine flour. Two patients allergic to lupine but not to peanut displayed IgE binding predominantly to approximately 66-kd proteins and weak binding to 14- and 24-kd proteins, whereas patients with peanut allergy and lupine allergy showed weak binding to lupine proteins of about 14 to 21 or 66 kd. Inhibition of binding was primarily species specific. CONCLUSION: Lupine allergy can occur either separately or together with peanut allergy, as demonstrated by 3 patients who are cosensitized to peanut and lupine. CLINICAL IMPLICATIONS: Lupine flour is allergenic and potentially cross-reactive with peanut allergen, thus posing some risk if used as a replacement for soy flour.
Assuntos
Arachis/imunologia , Hipersensibilidade Alimentar/etiologia , Hipersensibilidade Alimentar/imunologia , Glycine max/imunologia , Lupinus/imunologia , Adulto , Reações Cruzadas , Feminino , Humanos , Immunoblotting , Masculino , Pessoa de Meia-Idade , Extratos Vegetais/imunologia , Testes CutâneosAssuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Ácido Fusídico/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Antibacterianos/uso terapêutico , Dermatite Atópica/tratamento farmacológico , Dermatite Atópica/microbiologia , Ácido Fusídico/uso terapêutico , Humanos , Países Baixos/epidemiologia , Staphylococcus aureus/patogenicidadeRESUMO
Myelodysplastic syndrome (MDS) is an uncommon but serious complication of patients who undergo autologous bone marrow transplantation (auto-BMT) for non-Hodgkin's lymphoma or Hodgkin's disease. Some patients exhibit an indolent course, but others succumb to aggressive disease. p53 overexpression is rare in de novo MDS but common in therapy-associated MDS. We used an immunostaining method to analyze expression of p53, the p53-associated tumor suppressor gene products, MDM2, p21waf1, retinoblastoma gene protein (pRB), and the antiapoptotic oncoprotein bcl-2 before and after BMT in BM specimens from eight patients with clonal karyotypic abnormalities characteristic of MDS. Staining was compared with findings in normal BM specimens and specimens from auto-BMT controls and patients with de novo MDS. p53 protein was found in three (75%) of four post-transplantation specimens from patients in whom a clinically aggressive form of MDS developed. In contrast, p53 was absent in all of the specimens from four patients with karyotypic evidence of MDS, but with indolent disease. bcl-2 protein was overexpressed by immature myeloid cells in seven of eight pre-BMT specimens. After BMT, it was predominantly found at low levels in cases positive for p53. MDM2 was present only after transplantation and was found with equal frequency in patients with indolent and aggressive MDS. We detected p21waf1 in only one aggressive post-BMT MDS specimen. pRB was normally expressed in all of the specimens. These data show that p53 and bcl-2 staining patterns in post-transplantation MDS are similar to those described in therapy-associated MDS. p53 positivity is associated with poor prognosis in auto-BMT patients with MDS. Expression of MDM2, p21waf1, and pRB in this group of patients is not helpful in predicting outcome.
Assuntos
Transplante de Medula Óssea/efeitos adversos , Ciclinas/metabolismo , Linfoma/terapia , Síndromes Mielodisplásicas/metabolismo , Proteínas Nucleares , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteínas Proto-Oncogênicas/metabolismo , Proteína do Retinoblastoma/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Inibidor de Quinase Dependente de Ciclina p21 , Doença de Hodgkin/patologia , Doença de Hodgkin/terapia , Humanos , Técnicas Imunoenzimáticas , Linfoma/patologia , Linfoma não Hodgkin/patologia , Linfoma não Hodgkin/terapia , Síndromes Mielodisplásicas/etiologia , Síndromes Mielodisplásicas/patologia , Proteínas de Neoplasias/metabolismo , Proteínas Proto-Oncogênicas c-mdm2 , Transplante AutólogoRESUMO
The role of surface antigens in the density-dependent inhibition of primary immune response in mouse spleen cell cultures was investigated. For this purpose Fab-fragments of rabbit IgG obtained after immunization with mouse splenocytes were used. Such Fab-fragments alone had no effect on immune response in both optimal and dense cultures. However, successive treatment of cells with Fab-fragments and with ass antibodies against rabbit IgG dramatically augmented the density-dependent inhibition of antibody formation.
Assuntos
Formação de Anticorpos , Antígenos de Superfície/imunologia , Fragmentos Fab das Imunoglobulinas/imunologia , Baço/imunologia , Animais , Meios de Cultura , Camundongos , Camundongos Endogâmicos C57BLRESUMO
A study was made of the effect of mitogens on general proliferation and primary immune response to sheep red blood cells in density-inhibited cultures of mouse spleen cells. The mitogens applied included fetal calf serum and both B cell- and T cell-specific mitogens (dextran sulfate, LPS and ConA). Experiments with 3H-thymidine incorporation demonstrated that the proliferation was equally enhanced by any mitogen in both optimal and density-inhibited cultures. The mitogens did not remove the density inhibition of antibody formation.